Pulling SEC filings + quote and writing the call…
ANIK
Anika Therapeutics, Inc.
Next earnings Jul 28, 2026 · consensus $-0.08 EPS, $29.8M rev
Last earnings -18.8% on 2026-04-29
$14.30
▼ -0.83%$14.42▲ +29.79%
over 1Y
L $8.10EODHDH $16.00
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-0.8%
1W-2.0%
1M-2.7%
3M+1.7%
YTD+54.2%
1Y+29.8%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 8 analysts
Buy
Revenue declined -5.9% YoY.
Anika Therapeutics, Inc. shows $113M in FY2025 revenue (-5.9% YoY), a -9.6% net margin, and -7.6% ROE.
Sources: SEC EDGAR (CIK 0000898437, latest 10-Q filed 2026-04-30) · EODHD · as of 6/22/2026, 2:57:31 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.